The Best Optical Wholesale Directory
Optical Vision Blog
Barton Perreira, purveyors of luxury eyewear showcases his 2010 Spring-Summer collection, featuring Giovanni Ribisi. Giovanni Ribisi is an american actor who’s film credits include, Saving Private Ryan, The Mod Squad, Gone in 60 seconds, Lost In Translation and more.
-->
Evatik Style 9014
Classique Eyewear new eyeglass collection just for men is just handsome. It is hard to find a mens collection that doesn’t look like everything else in the optical marketplace. The bold temples yet sleek design give off an aura of power or as Classique Eyewear says an aura of mystery.
To find out more about Classique Eyewear new collection Evatik, you can call them at 866.604.5700, visit their site to view the full collection.
LONGARONE, Italy, Mar 08, 2010 (BUSINESS WIRE) — Kenneth Cole Productions, Inc. /quotes/comstock/13*!kcp/quotes/nls/kcp (KCP 13.25, -0.19, -1.43%) , the New York-based fashion house, and the Marcolin Group, a leader in the eyewear industry, announce the advance renewal of their licensing agreement for production and distribution of prescription frames and sunglasses under the Kenneth Cole New York and Kenneth Cole Reaction labels through 2014. The terms and conditions are in line with those included in the current agreement that was due to expire on December 31, 2011.
The collaboration with Kenneth Cole Productions represents one of the many long-term partnerships of the Marcolin Group. The first licensing agreement with the Company was for the production and distribution of sunglasses through department, specialty and retail stores in the United States in 2003. In October 2004, a new licensing agreement was signed for the production and distribution in the U.S. optical channel of both prescription frames and sunglasses. At the end of 2005, the parties extended the agreements for distribution on a worldwide basis. Read the full Story At Market Watch
Another ophthalmologist in the US has been banned from carrying out laser eye surgery procedures after being found guilty of failing to ensure his patients safety during and after surgery.
The doctor, who has been sued some 50 times since the 1990s for medical malpractice, was accused of mishandling laser eye surgeries and failing to “properly manage treatment of post-operative complications”.
The Illinois Department of Financial and Professional Regulation has suspended Dr Nicholas Caro’s medical license for 30 days and have placed him on probation for three years. Read the full story at igo lenses
New CNIB survey finds older Canadians putting eye health at risk
Eye Care About Canada campaign raises awareness about glaucoma
TORONTO, March 8 /CNW/ – According to a new CNIB survey released today for World Glaucoma Week (March 7-13), older Canadians are not taking the necessary steps to protect their eyes from glaucoma – the second-leading cause of vision loss in seniors.
The survey found that nearly half (47 per cent) of Canadians age 40 and older are not getting regular eye exams. Many only see their eye doctor once problems arise, despite the fact that glaucoma has no symptoms and is usually painless.
“People tend to assume that they have healthy eyes because they are not experiencing any symptoms like pain or red in the eye, but glaucoma is really a silent thief,” said Dr. Keith Gordon, Vice President of Research and Service Quality, CNIB. “Unfortunately in Canada, only half of the 250,000 Canadians living with glaucoma even know they have it. And if left untreated, over time it can lead to progressive and permanent vision loss; the disease could progress without a person knowing it.”
The survey found that 71 per cent of respondents would make an appointment with their eye doctor if they experienced symptoms including blurry vision (66 per cent), pain in the eye (45 per cent), and itchy or red eyes (each 15 per cent); referral by family doctor (44 per cent) will also prompt a visit. But having a family history of eye disease isn’t enough to prompt one quarter (24 per cent) of respondents to have an eye examination, despite the fact that family history – particularly having a parent with the disease – is considered one of the primary risk factors for glaucoma.
“While there is no cure for glaucoma, there are treatment options available to control the disease and prevent it from progressing if it’s detected early,” said Dr. Yvonne Buys, Professor, Department of Ophthalmology and Vision Sciences, University of Toronto and Immediate Past President of the Canadian Glaucoma Society. “That’s why it’s so important especially for older Canadians to have regular eye exams.” Read the full story at CNW
Expect to see the Christian Lacroix brand in more places than on the red carpet. The former French couture house is finally putting its licensing operation into gear with new deals in sunglasses, stationery, home furnishings, and décor.
This summer, Lacroix and French company Marotte will launch decorative wood panels for the home. Come September, Lacroix will release women’s eyeglass frames and sunglasses with Hong Kong-based Mondottica, as well as premium stationery with New York’s Libretto Holdings. The high-end stationery line will most likely include fashion illustrations by the designer himself. UK-based Designers Guild will also launch home textiles with Lacroix in early 2011. Read the full story at Stylecaster.com
Monrovia, CA—The Japanese Ministry of Health, Labor and Welfare (MHLW) has given regulatory approval for STAAR Surgical Co. to market its implantable contact lens (Visian Implantable Collamer Lens) in that country for the treatment of myopia.
Barry G. Caldwell, president and chief executive officer of STAAR Surgical, called the approval “a major milestone” for the company.
“Japan is currently the third largest refractive market and offers an opportunity for additional growth,” he said, noting the higher incidence of myopia in the Japanese population compared with other populations.
STAAR Japan is executing the launch plan, anticipates offering certification courses for the lens beginning this month, and expects to begin generating revenue from the product line in the first half of this year, according to David Bailey, president of international operations at STAAR. He added that the company has been working with regulatory agencies for several years. Read the full story at Modern Medicine